Dr. Carl June: "I think we're on the threshold. We now know it's possible to do genetic editing with exquisite precision at levels with therapeutic relevance."
Read more
CytoVas develops cellular assays that can be commercialized as in-vitro diagnostics for the measurement of the personal risk for cardiovascular disease.
Read more
John Lambris, PhD, and Daniel Ricklin, PhD, are co-authors of a recent study describing a possible new way to fight a disease that is currently treatable only with the most expensive drug available for sale in the United States. The research team outlines a strategy based on the complement system, the oldest part of the human immune system, that could turn out to be less costly and more effective for the majority of patients with the rare but life-threatening hematological disorder paroxysmal nocturnal hemoglobinuria (PNH).
Read more
The February 13, 2014, issue of Laboratory Industry Report covers a recent Department of Health and Human Services (HHS) decision to require laboratories to send test results directly to patients if requested. The report notes that, while the ruling should not have a significant impact on laboratory test volumes, it could affect of the business model of clinical laboratories.
Read more
Diplomate status certifies rigorous educational and experiential eligibility requirements and demonstrates the knowledge and skills necessary to direct laboratories that are engaged in the microbiological diagnosis of human disease.
Read more
Daniel Powell, PhD, Research Associate Professor of Pathology and Laboratory Medicine and a member of the Ovarian Cancer Research Center at the Abramson Cancer Center, has been selected by the American Society of Gene & Cell Therapy (ASGCT) as one of four recipients of the ASGCT's 2014 Outstanding New Investigator Award. The award recipients are newly independent researchers who are selected by the ASGCT Board of Directors based upon various significant contributions to the field of gene and cell therapy.
Read more
The lab of David Weiner, PhD, professor of Pathology and Laboratory Medicine, and colleagues report in Cancer Research this week that the protein IL-33 boosts the immune system of a human papilloma virus animal model of cancer. IL-33 is a cytokine, a small protein that signals immune cells such as T cells to travel to a site of infection or injury.
Read more
Xiaowei “George” Xu, MD, PhD, and colleagues have devised a method for converting adult cells into epithelial stem cells (EpSCs), the first time anyone has achieved this in either humans or mice.
Read more
The Blood publication caught the attention of the Director of the NIH, Dr. Francis Collins, who discusses the researchers' NIH-funded findings in his "Director's Blog" post "Cellular Shape-Shifters to the Rescue."
Read more
Four department faculty members were honored with Excellence in Teaching Awards at the Perelman School of Medicine Class of 2016 awards ceremony on December 12. The teaching awards are selected by the entire class of second-year medical students and represent what the students think are the ideals in teaching excellence. Among this year's recipients of the student teaching awards are:
Read more
Pages
